127 related articles for article (PubMed ID: 8957063)
1. Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan.
Wu MS; Lin YW; Sheu JC; Wang HP; Wang JT; Shun CT; Lee WJ; Wang TH; Lin JT
Jpn J Cancer Res; 1996 Oct; 87(10):1052-5. PubMed ID: 8957063
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
4. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
[TBL] [Abstract][Full Text] [Related]
5. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.
Hebert J; Cayuela JM; Berkeley J; Sigaux F
Blood; 1994 Dec; 84(12):4038-44. PubMed ID: 7994022
[TBL] [Abstract][Full Text] [Related]
6. Alterations of CDKN2 (p16) in non-small cell lung cancer.
de Vos S; Miller CW; Takeuchi S; Gombart AF; Cho SK; Koeffler HP
Genes Chromosomes Cancer; 1995 Nov; 14(3):164-70. PubMed ID: 8589032
[TBL] [Abstract][Full Text] [Related]
7. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
[TBL] [Abstract][Full Text] [Related]
8. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Siebert R; Willers CP; Schramm A; Fosså A; Dresen IM; Uppenkamp M; Nowrousian MR; Seeber S; Opalka B
Br J Haematol; 1995 Oct; 91(2):350-4. PubMed ID: 8547074
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the p16 and p15 genes in human bladder tumors.
Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
[TBL] [Abstract][Full Text] [Related]
10. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
[TBL] [Abstract][Full Text] [Related]
11. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia.
Cayuela JM; Madani A; Sanhes L; Stern MH; Sigaux F
Blood; 1996 Mar; 87(6):2180-6. PubMed ID: 8630377
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
15. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Li LC; Dahiya R
Int J Cancer; 1999 Nov; 83(5):610-4. PubMed ID: 10521795
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers.
Shimizu T; Sekiya T
Int J Cancer; 1995 Nov; 63(5):616-20. PubMed ID: 7591275
[TBL] [Abstract][Full Text] [Related]
17. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours.
Shih YC; Kerr J; Liu J; Hurst T; Khoo SK; Ward B; Wainwright B; Chenevix-Trench G
Int J Cancer; 1997 Mar; 70(5):508-11. PubMed ID: 9052747
[TBL] [Abstract][Full Text] [Related]
18. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
Schulte KM; Staudt S; Niederacher D; Finken-Eigen M; Köhrer K; Goretzki PE; Röher HD
Horm Metab Res; 1998 Sep; 30(9):549-54. PubMed ID: 9808321
[TBL] [Abstract][Full Text] [Related]
19. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
Iravani M; Dhat R; Price CM
Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]